Edap TMS SA (EDAP)
5.95
+0.18
(+3.12%)
USD |
NASDAQ |
May 31, 16:00
6.00
+0.05
(+0.84%)
After-Hours: 20:00
Edap TMS Cash from Investing (Quarterly): -1.193M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.193M |
| December 31, 2023 | -0.8921M |
| September 30, 2023 | -0.9178M |
| June 30, 2023 | -1.617M |
| March 31, 2023 | -1.276M |
| December 31, 2022 | 17.38M |
| September 30, 2022 | -18.61M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.4932M |
| March 31, 2022 | -0.7765M |
| December 31, 2021 | -0.7731M |
| September 30, 2021 | -0.3888M |
| June 30, 2021 | -0.4219M |
| March 31, 2021 | -0.3543M |
| March 31, 2020 | -2.219M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-18.61M
Minimum
Sep 2022
17.38M
Maximum
Dec 2022
-0.8972M
Average
-0.8343M
Median
Cash from Investing (Quarterly) Benchmarks
| Cellectis SA | -2.051M |
| DBV Technologies SA | -2.132M |
| Genfit SA | -- |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0545M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.073M |
| Cash from Financing (Quarterly) | -0.1814M |
| Free Cash Flow | -20.17M |
| Free Cash Flow Per Share (Quarterly) | -0.1423 |
| Free Cash Flow to Equity (Quarterly) | -3.302M |
| Free Cash Flow to Firm (Quarterly) | -5.266M |
| Free Cash Flow Yield | -9.16% |